DIAアカウントをお持ちの場合、サインインしてください。

サインイン

ユーザーIDをお忘れですか? or パスワードをお忘れですか?

東京ビッグサイト | 有明

2018年11月11日 (日) 午前 9:30 - 2018年11月13日 (火) 午後 5:40

〒135-0063, 東京都江東区有明3-11-1

第15回DIA日本年会

未曾有の変革の時代、イノベーション創出とグローバルヘルスへの貢献を、どのような連携の下で進めていくか

[V5-S6] The Latest Trend of Vaccine Policy, Regulatory Regulation in Japan, the United States and Europe

Session Chair(s)

Nobuhiko  Okabe, MD

Nobuhiko Okabe, MD

Director General, Kawasaki City Institute for Public Health, Japan

Although vaccination has largely contributed to the improvement and promotion of public health, prevention of infection by vaccination will become increasingly important for the Tokyo Olympic Games to be held in 2020. In this session, we introduce the vaccination system and examination in Japan, the United States and Europe, and discuss how the differences in the system influence vaccination promotion from various viewpoints. We will also discuss experiences on benefits gained by vaccination and expectations for future vaccine administration.

Speaker(s)

Akihiko  Saitoh, MD

Akihiko Saitoh, MD

Professor, School of Medicine Department of Pediatrics, Niigata University, Japan

Immunization System in Japan - Recent Progress and Challenges -

Ercem S Atillasoy, MD

Ercem S Atillasoy, MD

Vice President, Merck & Co., Inc, United States

Regulatory Trends and Current Challenges for Vaccine Development in the USA

Shazia  Sheikh

Shazia Sheikh

Director, Communications & Government Affairs, Emerging Markets, GSK Vaccines, Belgium

Immunisation in Europe: an overview

Andrew  Otoo, PHARMD, MBA

Andrew Otoo, PHARMD, MBA

VP, Japan Vaccines Country Lead, Pfizer Japan Inc., Japan

最新情報や機会を逃さないで

DIAのメールを購読すれば、常に最新の業界情報やイベント情報を得ることができます。